| Literature DB >> 16957654 |
Abstract
A clinically important subset of patients with erosive esophagitis will not attain adequate symptom relief and healing on once-a-day proton pump inhibitor therapy. This is especially true in patients with frequent and nocturnal heartburn and in those with Los Angeles Grades C and D erosive esophagitis. The approach to evaluation and management of cases of refractory or difficult gastroesophageal reflux disease is the subject of this state-of-the-art review.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16957654
Source DB: PubMed Journal: Rev Gastroenterol Disord ISSN: 1533-001X